Skip to main content
Premium Trial:

Request an Annual Quote

Ariadne, OU Team Up to Offer Cancer-Related Pathway Collection

NEW YORK (GenomeWeb News) — Ariadne Genomics said today that it has partnered with the University of Oklahoma to develop a cancer-related pathways collection.
 
The collection will then become available to Ariadne customers as an add-on to its pathway-analysis product line, according to the company.
 
The University of Oklahoma has already deployed Ariadne’s Pathway Studio software tool to develop a collection of cancer-related pathways.
 
Dee Wu, associate professor at the OU Health Sciences Center, said that the university will “perform scientific evaluation of pathway expansion and microarray data analysis algorithms available in Pathway Studio” in order to “build up a collection of cancer-related pathways using its built-in ResNet database and advanced pathway reconstruction and literature mining tools.”
 
Financial details were not discussed.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.